SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-035343
Filing Date
2023-12-27
Accepted
2023-12-27 07:48:22
Documents
15
Period of Report
2023-12-22
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K zvra20231226_8k.htm   iXBRL 8-K 34211
2 EXHIBIT 99.1 ex_610089.htm EX-99.1 15025
7 picture3.jpg GRAPHIC 5788
  Complete submission text file 0001437749-23-035343.txt   194812

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zvra-20231222.xsd EX-101.SCH 3411
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zvra-20231222_def.xml EX-101.DEF 11438
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE zvra-20231222_lab.xml EX-101.LAB 15343
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zvra-20231222_pre.xml EX-101.PRE 11598
9 EXTRACTED XBRL INSTANCE DOCUMENT zvra20231226_8k_htm.xml XML 2653
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 231514642
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)